These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 34927506)

  • 1. Novel polysaccharide building hybrid nanoparticles: remodelling TAMs to target ERα-positive breast cancer.
    Guo C; Su Y; Wang B; Chen Q; Guo H; Kong M; Chen D
    J Drug Target; 2022 Apr; 30(4):450-462. PubMed ID: 34927506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of dual-targeted nano-dandelion based on an oligomeric hyaluronic acid polymer targeting tumor-associated macrophages for combination therapy of non-small cell lung cancer.
    Wang B; Zhang W; Zhou X; Liu M; Hou X; Cheng Z; Chen D
    Drug Deliv; 2019 Dec; 26(1):1265-1279. PubMed ID: 31777307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
    Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
    Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
    [No Abstract]   [Full Text] [Related]  

  • 4. Novel nano-pomegranates based on astragalus polysaccharides for targeting ERα-positive breast cancer and multidrug resistance.
    Wang B; Guo C; Liu Y; Han G; Li Y; Zhang Y; Xu H; Chen D
    Drug Deliv; 2020 Dec; 27(1):607-621. PubMed ID: 32308054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor microenvironment targeting with dual stimuli-responsive nanoparticles based on small heat shock proteins for antitumor drug delivery.
    Shi K; Wang Y; Zhou X; Gui H; Xu N; Wu S; He C; Zhao Z
    Acta Biomater; 2020 Sep; 114():369-383. PubMed ID: 32688090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage-reprogramming upconverting nanoparticles for enhanced TAM-mediated antitumor therapy of hypoxic breast cancer.
    Yoon J; Le XT; Kim J; Lee H; Nguyen NT; Lee WT; Lee ES; Oh KT; Choi HG; Youn YS
    J Control Release; 2023 Aug; 360():482-495. PubMed ID: 37423526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells.
    Zhang F; Wang X; Xu X; Li M; Zhou J; Wang W
    Eur J Pharm Sci; 2016 Sep; 92():11-21. PubMed ID: 27343697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delivery of baicalein and paclitaxel using self-assembled nanoparticles: synergistic antitumor effect in vitro and in vivo.
    Wang W; Xi M; Duan X; Wang Y; Kong F
    Int J Nanomedicine; 2015; 10():3737-50. PubMed ID: 26045664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
    He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
    Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Palmitic acid-modified human serum albumin paclitaxel nanoparticles targeting tumor and macrophages against breast cancer.
    Xiang L; Fang C; Feng J; Tan Y; Wu Q; Zhou X; Li J; Gong T
    Eur J Pharm Biopharm; 2023 Feb; 183():132-141. PubMed ID: 36592736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide-guided resiquimod-loaded lignin nanoparticles convert tumor-associated macrophages from M2 to M1 phenotype for enhanced chemotherapy.
    Figueiredo P; Lepland A; Scodeller P; Fontana F; Torrieri G; Tiboni M; Shahbazi MA; Casettari L; Kostiainen MA; Hirvonen J; Teesalu T; Santos HA
    Acta Biomater; 2021 Oct; 133():231-243. PubMed ID: 33011297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paclitaxel-loaded biodegradable ROS-sensitive nanoparticles for cancer therapy.
    Pandya AD; Jäger E; Bagheri Fam S; Höcherl A; Jäger A; Sincari V; Nyström B; Štěpánek P; Skotland T; Sandvig K; Hrubý M; Mælandsmo GM
    Int J Nanomedicine; 2019; 14():6269-6285. PubMed ID: 31496685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel multi-targeted nanoparticles for targeted co-delivery of nucleic acid and chemotherapeutic agents to breast cancer tissues.
    Amani A; Alizadeh MR; Yaghoubi H; Nohtani M
    Mater Sci Eng C Mater Biol Appl; 2021 Jan; 118():111494. PubMed ID: 33255061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel free-paclitaxel-loaded redox-responsive nanoparticles based on a disulfide-linked poly(ethylene glycol)-drug conjugate for intracellular drug delivery: synthesis, characterization, and antitumor activity in vitro and in vivo.
    Chuan X; Song Q; Lin J; Chen X; Zhang H; Dai W; He B; Wang X; Zhang Q
    Mol Pharm; 2014 Oct; 11(10):3656-70. PubMed ID: 25208098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted antitumor comparison study between dopamine self-polymerization and traditional synthesis for nanoparticle surface modification in drug delivery.
    Zhang M; Zou Y; Zuo C; Ao H; Guo Y; Wang X; Han M
    Nanotechnology; 2021 May; 32(30):. PubMed ID: 33862617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paclitaxel/methotrexate co-loaded PLGA nanoparticles in glioblastoma treatment: Formulation development and in vitro antitumor activity evaluation.
    Madani F; Esnaashari SS; Bergonzi MC; Webster TJ; Younes HM; Khosravani M; Adabi M
    Life Sci; 2020 Sep; 256():117943. PubMed ID: 32531377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanotherapy delivery of c-myc inhibitor targets Protumor Macrophages and preserves Antitumor Macrophages in Breast Cancer.
    Esser AK; Ross MH; Fontana F; Su X; Gabay A; Fox GC; Xu Y; Xiang J; Schmieder AH; Yang X; Cui G; Scott M; Achilefu S; Chauhan J; Fletcher S; Lanza GM; Weilbaecher KN
    Theranostics; 2020; 10(17):7510-7526. PubMed ID: 32685002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving antitumor outcomes for palliative intratumoral injection therapy through lecithin- chitosan nanoparticles loading paclitaxel- cholesterol complex.
    Chu XY; Huang W; Wang YL; Meng LW; Chen LQ; Jin MJ; Chen L; Gao CH; Ge C; Gao ZG; Gao CS
    Int J Nanomedicine; 2019; 14():689-705. PubMed ID: 30774330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-delivery of paclitaxel and STAT3 siRNA by a multifunctional nanocomplex for targeted treatment of metastatic breast cancer.
    Luo K; Gao Y; Yin S; Yao Y; Yu H; Wang G; Li J
    Acta Biomater; 2021 Oct; 134():649-663. PubMed ID: 34289420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paclitaxel and quercetin co-loaded functional mesoporous silica nanoparticles overcoming multidrug resistance in breast cancer.
    Liu M; Fu M; Yang X; Jia G; Shi X; Ji J; Liu X; Zhai G
    Colloids Surf B Biointerfaces; 2020 Dec; 196():111284. PubMed ID: 32771817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.